Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of oxytocin acetate injection in China. Welcome to wholesale bulk high quality oxytocin acetate injection for sale here from our factory. Good service and reasonable price are available.
Oxytocin Acetate Injection is an aseptic aqueous solution. Its main active ingredient is acetate oxytocin, a chemically synthesized polypeptide hormone that is identical to the naturally secreted oxytocin in the human body. This drug is mainly used in the field of obstetrics. By mimicking the physiological effects of natural oxytocin, it stimulates the smooth muscle of the uterus in the late stage of pregnancy to produce rhythmic contractions, thereby inducing and strengthening the labor process, or being used after a cesarean section to control uterine bleeding. Its effect is rapid but short-lived. After intravenous administration, it takes effect quickly, but it must be used under strict medical supervision.
The dosage and infusion rate need to be precisely controlled by professional medical staff because excessive oxytocin may cause excessive uterine contractions or even rupture, fetal distress and other serious complications. Additionally, it is occasionally used to promote milk secretion after childbirth. The product is usually in the form of ampoules or vials and needs to be stored in a dark place and refrigerated. It should be used strictly in accordance with aseptic operation norms. Contraindications include obvious cephalopelvic disproportion, abnormal fetal position, placenta previa and other conditions that may pose risks for vaginal delivery. It is a crucial and potent prescription drug in obstetric management.
|
|
|
Oxytocin Acetate COA
Oxytocin acetate injection is an artificially synthesized peptide hormone drug. The core component, Oxytocin, is chemically modified (in the form of acetate) to enhance its solubility and stability. It is widely used in obstetrics, gynecology, and assisted reproductive fields. Its safety and stability directly affect the clinical efficacy and patient safety, and need to be comprehensively evaluated from multiple dimensions such as drug characteristics, production process, storage conditions, and clinical application.
Safety Analysis
Drug Mechanism of Action
Oxytocin acts by activating the G protein-coupled receptors on the cell membranes of uterine smooth muscle cells, promoting calcium ion influx and triggering uterine contractions. Its effect is dose-dependent: a low dose (1-2 mU/min) can induce regular contractions, while a high dose (>5 mU/min) may lead to paroxysmal contractions, increasing the risks of uterine rupture and fetal distress. Additionally, oxytocin may cross the blood-brain barrier and affect the central nervous system, causing adverse reactions such as nausea, vomiting, and headache, but the incidence is relatively low (about 5%-10%).
Clinical risk control:
Individualized dose adjustment: Dynamically adjust the infusion rate based on the mother's weight, gestational age, and uterine contraction intensity to avoid "one-size-fits-all" medication.
Real-time monitoring: Combine fetal heart rate monitoring (CTG) and uterine contraction pressure monitoring to ensure a balance between fetal oxygen supply and uterine contractions.
Adverse reaction management: Strictly exclude high-risk factors such as multiple pregnancies, placental abruption, and cephalopelvic disproportion, to reduce the risk of complications.
Allergic reactions and immunogenicity
Uterine oxytocin, as a peptide-based drug, theoretically has an immunogenicity risk. However, in actual clinical practice, severe allergic reactions are extremely rare. Its low immunogenicity is attributed to:Molecular weight is small, making it difficult for antigen-presenting cells to recognize it;Chemical modification: Acetate form reduces protein aggregation and lowers immunogenicity;Short half-life, and rapid metabolism of the drug reduces accumulation in the body.Precautions:Before administration, inquire about the history of allergies. Those who are allergic to known peptide drugs should not use it;During the first infusion, closely observe for 15-30 minutes and prepare adrenaline and other emergency medications.
Safety for specific populations
Pregnancy: FDA classification is C grade (animal experiments show risks, limited human data). However, the clinical consensus is that the benefits outweigh the risks, and it is the first-line medication for postpartum hemorrhage (PPH).Lactation: Oxytocin can enter the breast milk in small amounts, but there is no evidence that it is harmful to the infant. There is no need to discontinue breastfeeding.Those with impaired liver or kidney function: The drug metabolism mainly relies on renal excretion. Severe renal insufficiency requires dose adjustment or prolonging the dosing interval.
Stability analysis
Chemical stability
The stability of acetic this med is significantly affected by pH value, temperature, light exposure, and oxidants:
pH value: The optimal range is 3.5 - 5.5. Deviation from this range may lead to hydrolysis or deamidation of the polypeptide chain, resulting in the formation of ineffective degradation products.
Temperature: Refrigeration at 2 - 8℃ can maintain stability for 24 - 36 months. Degradation rate can reach 10% - 15% within 7 days at room temperature (25℃). High temperature (40℃) accelerates degradation and forms impurities such as dimerization.
Light: Ultraviolet rays can induce photo-oxidation reactions, generating potentially toxic peroxides. It is necessary to store in a dark place.
Oxidants: Such as hydrogen peroxide and sodium hypochlorite, can break disulfide bonds, causing the drug to lose its activity.
Quality control standards:
High-performance liquid chromatography (HPLC) detects the purity of the main peak ≥ 98%;
The forced degradation test (such as acid, alkali, heat, light, and illumination) verifies the impurity profile to ensure that the total impurities are < 2%.
Physical stability
Solution clarity: Microcrystals may precipitate when stored at low temperatures, and it is necessary to slowly warm to room temperature before use to avoid direct heating or vigorous shaking.
Container compatibility: Glass ampoules should use neutral borosilicate glass to avoid the precipitation of alkaline substances leading to pH changes; plastic containers should verify the drug adsorption rate (usually < 5%).
Sterility: Terminal sterilization (such as moist heat sterilization at 121°C for 15 minutes) may damage the peptide structure, and aseptic filtration + low-temperature drying process is usually adopted, combined with double-layer aluminum foil packaging to isolate microorganisms.
Stability management in clinical use
Stability after reconstitution: Freeze-dried powder injectables need to be stored at 2-8°C after reconstitution and used within 24 hours; it is recommended to use within 4 hours at room temperature to avoid repeated freezing and thawing.Infusion system compatibility: Special infusion pumps should be used to avoid contact with PVC pipes containing DEHP (di-tert-butyl phthalate), to prevent the release of plasticizers that affect drug stability.Treatment of remaining drug solution: Single-dose packaging (such as 1 mL: 10 U) can reduce waste, while multi-dose packaging requires strict aseptic operation to avoid cross-contamination.
The Correlation between Safety and Stability
Drug stability directly affects safety: Degradation products may reduce efficacy or cause toxicity.
For example, the deamidation of this med leads to a 50%-70% decrease in activity, while the dimer may prolong the half-life and increase the risk of excessive uterine stimulation.
Therefore, strict quality control (such as forced degradation tests, long-term stability studies) is necessary to ensure the safety of the drug within the effective period.
The oxytocin acetate injection is highly safe when used according to the guidelines. However, the dosage must be strictly controlled, adverse reactions need to be monitored, and contraindications must be excluded. Its stability is significantly affected by temperature, light exposure, and packaging materials. Quality must be ensured through measures such as cold chain transportation, light protection, and compatibility verification. In the future, with the development of formulation technologies (such as liposome encapsulation and nano-crystal technology), the stability of the drug can be further extended, reducing the risks associated with clinical medication.
How does oxytocin covertly regulate the reproductive cycle?
Oxytocin acetate injection, a peptide hormone synthesized by the hypothalamus and released by the neurohypophysis, is often regarded as the "delivery trigger" or the "intimate hormone". However, its regulation of the reproductive rhythm goes far beyond simply initiating uterine contractions. It adjusts the rhythm "in the background" during multiple stages of reproduction through a complex neuroendocrine network, multi-organ synergy, and environmental adaptation mechanisms, ensuring the efficiency and safety of the reproductive process. The following will analyze its regulatory logic from four dimensions.
Initiation of Labor: From "Silent Preparation" to "Precise Burst"
Oxytocin does not suddenly appear at the moment of labor. Instead, it prepares for labor through long-term, low-level secretion, and finally achieves "burst-like" release under specific signals, forming a three-stage regulatory process of "silence - activation - reinforcement".
"Pre-adaptation" in the late pregnancy stage
In the later stages of pregnancy, the level of estrogen secreted by the placenta surges, prompting the expression of more this med receptors in uterine smooth muscle cells and increasing intracellular calcium reserves. Although the concentration of this med in the blood has not significantly increased at this time, the uterus is already in a "highly sensitive state", preparing structurally for childbirth. This "pre-adaptation" mechanism ensures that when the delivery signal arrives, the uterus can respond quickly and avoid difficult labor due to slow response.
"Integration and amplification" of the delivery signal
The actual trigger for childbirth is the coordinated action of multiple signals: after the fetal hypothalamic-pituitary-adrenal axis matures, it secretes cortisol, promoting the synthesis of prostaglandins by the placenta, while mechanical traction generated by cervical dilation stimulates the sensory neurons of the maternal hypothalamic paraventricular nucleus. These signals amplify this med release through a "positive feedback loop": the first uterine contraction compresses the cervix → mechanical stimulation increases → oxytocin secretion increases → uterine contraction intensity increases → further compression of the cervix → ultimately forming an irreversible delivery process.
"Self-calibration" of the rhythm
The secretion of this med has a pulsed characteristic, with each pulse interval approximately 3-5 minutes, synchronized with the uterine contraction cycle. This rhythmic release is regulated by γ-aminobutyric acid -ergic neurons in the arcuate nucleus of the hypothalamus to ensure that the intensity of uterine contractions gradually increases,while avoiding excessive fatigue of the uterus. If the uterine contractions are too strong, causing fetal hypoxia, the fetus will release β-endorphin to inhibit the secretion of maternal oxytocin, forming a self-protection mechanism of "mother-fetus dialogue".
Postpartum recovery: The rhythm transition from "contraction to stop bleeding" to "breast milk ejection"
After childbirth, this med rapidly switches functions and regulates uterine contractions and breast milk ejection to complete the rhythm transition from "reproduction" to "breastfeeding".
"Precise Timing of Uterine Recovery"
After the placenta is delivered, the uterus needs to return to its pre-pregnancy size within 6 weeks. Oxytocin continuously stimulates the contraction of uterine smooth muscle, compressing the vascular ends and reducing postpartum hemorrhage (PPH). Its secretion rhythm matches the progress of uterine recovery: it is released at a high frequency (once every 10-15 minutes) in the early postpartum period, promoting the formation of blood clots at the placental separation site; then it gradually reduces the frequency to avoid excessive uterine contractions that affect the healing of the placental attachment site.
"Condition Reflex for Breast Milk Ejection"
When the baby sucks on the nipple, mechanical stimulation is transmitted through the spinal cord to directly activate the this drug neurons in the maternal PVN, triggering the "milk ejection reflex". This process is highly time-sensitive: the this drug level rises within 30 seconds after the sucking begins, reaches its peak within 1 minute, and lasts for about 5 minutes. If the interval between two suckings exceeds 10 minutes, this drug secretion will significantly decrease, forcing the mother and baby to establish a "demand feeding" synchronous rhythm to optimize energy supply and the growth needs of the infant.
Environmental Adaptation: From "Stress Suppression" to "Social Synchronization" of Rhythm Adjustment
Oxytocin secretion is not only regulated by physiological signals but is also sensitive to external factors such as environmental stress and social interaction. It dynamically adjusts the reproductive rhythm to adapt to environmental changes.
"Childbirth Pause" under Stress Conditions
When the mother is in acute stress (such as hunger, fear, or pain), the hypothalamic-pituitary-adrenal axis (HPA axis) is activated, and the increase in cortisol levels will inhibit the activity of this drug neurons in the PVN and reduce this drug secretion. This mechanism is of great significance in evolution: pausing childbirth or breastfeeding in dangerous situations can prevent the mother and her offspring from being exposed to risks, thereby increasing the survival probability.
"Rhythm Acceleration" in Social Support
Positive social interactions (such as partner companionship, caressing, and gentle words) stimulate the brain reward system of the mother (such as the nucleus accumbens and prefrontal cortex), promoting this drug release. For example, mothers with the participation of a partner have 30%-50% higher this drug levels than those giving birth alone, and the average delivery time is shortened by 2 hours, and the risk of postpartum hemorrhage is reduced by 40%. This "social buffering effect" accelerates the rhythm of childbirth and optimizes reproductive outcomes.
Individual Differences: From "Genetic Polymorphism" to "Epigenetics"-Rhythm Customization
The function of the oxytocin system is influenced by both genetics and the environment. Different individuals have significant differences in their sensitivity to oxytocin, forming unique birth rhythms.
The "hardware differences" of genetic polymorphisms
The single nucleotide polymorphism (SNP) of the this drug receptor gene (OXTR) affects the expression level and binding affinity of the receptor. For instance, individuals with the G allele at the OXTR rs53576 locus are more sensitive to this drug and have stronger uterine contractions during childbirth and less postpartum bleeding; while those with the AA genotype may require a higher dose of exogenous this to induce childbirth.
The "software adjustment" of epigenetics
Early life experiences (such as maternal separation and abuse) can alter the expression of the OXTR gene through mechanisms such as DNA methylation and histone modification. For example, individuals who lacked maternal care during childhood have an elevated methylation level in the promoter region of the OXTR gene, which leads to a weakened response to this in adulthood and an increased risk of difficult labor or postpartum depression. This epigenetic regulation enables a long-term adaptation of the reproductive rhythm to the individual's psychological state.
Conclusion: Oxytocin-the "invisible conductor" of the reproductive rhythm
Oxytocin acetate injection regulates the reproductive rhythm "invisibly" at four levels: the initiation of childbirth, postpartum recovery, environmental adaptation, and individual differences. It is neither a simple "switch" nor an isolated "signal molecule", but rather acts through a multi-level, dynamic network to ensure a balance between efficiency and safety in the reproductive process. Understanding this mechanism not only provides a basis for optimizing clinical delivery management (such as individualized adjustment of oxytocin dosage) but also reveals the deep connection between human reproductive behavior and evolutionary adaptation.
FAQ
What are the benefits of oxytocin acetate peptide?
Oxytocin (OXT) has been shown to suppress appetite, induce weight loss, and improve glycemic control and lipid metabolism in several species, including humans, monkeys, and rodents.
What is the difference between oxytocin and oxytocin acetate?
This med is synthesized by the chemical conjugation of oxytocin with an acetic acid moiety. The stability of this molecule has been shown to be higher than that of oxytocin. This drug has been shown to have stronger binding affinity for the oxytocin receptor, which may be due to its increased molecular weight.
What is oxytocin acetate?
Oxytocin (α-Hypophamine) acetate is a pleiotropic, hypothalamic peptide known for facilitating parturition, lactation, and prosocial behaviors. Oxytocin acetate can function as a stress-coping molecule with anti-inflammatory, antioxidant, and protective effects especially in the face of adversity or trauma.
Hot Tags: oxytocin acetate injection, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale